Telma Sequeira

Thoracic oncology

[Telma Sequeira @TelmaSequeiraMD]

Talking about the possibility of cure in lung cancer 💪🏻

[Jarushka Naidoo @DrJNaidoo]

5yr outcomes Ph II NADIM trial:

- 5yr PFS 65% OS 69.3%
- pCR: 5yr PFS 92% OS 95.8%; nonpCR 60%&66%
- ctDNA clearance: 5yr PFS 85.2% OS 92.3%

‘pts disease-free beyond 3yrs, could be considered cured’

Powerful conclusion, powerful trial @MARIANOPROVENCI
https://t.co/8s1pnMq5cC

[Telma Sequeira @TelmaSequeiraMD]

Great team IASLC CME!! 😊 @IASLC

[Christian Rolfo @ChristianRolfo]

Starting the morning with the @IASLC Educational committee at #WCLC24 Great discussions and plans. Terrific group! @PranshuMohindra @HHorinouchi @paugalde20 @cbaldotto @PassigliaFra @Al3ssandroRusso @M_Tagliamento @RManochakian @mihaela_aldea @JPatelMD

[Stephen V Liu, MD @StephenVLiu]

#WCLC24 abstract titles released! Don't miss the plenary Sunday September 8th at 8:30am PDT - I am particularly eager to see the ivonescimab vs pembro HARMONi-2 data from Dr. Caicun Zhou, Neocoast-2 from Dr. Tina Cascone, and the 77T vs CM816 analysis from Dr. @FordePatrick!

[Telma Sequeira @TelmaSequeiraMD]

@ChristianRolfo @OSUCCC_James @OhioState Congrats @ChristianRolfo 🥳👏

[Telma Sequeira @TelmaSequeiraMD]

🌟 ASCO 2024 🌟 KRYSTAL12 results:
☑️ positive study: mPFS 5.5 vs 3.8 HR0.58
☑️ DCR 78% vs 59%
☑️ ADA showed intracranial efficacy in pts with M1 CNS

Nice to see the results of CT in which our patients are participating💪🏻 and benefiting
#ASCO24 #NSCLC #ipolisboa

[Telma Sequeira @TelmaSequeiraMD]

CM816…a game changer #ELCC2023

[Jordi Remon @JordiRemon]

CM816 trial 👑: Neoadjuvant chemo + IO improved 3-year EFS vs neoadj Ch alone with lowe 🧠 recurrences with chemoIO approach💡Challenges: Do we need ADJ IO after the neoadj CT+IO approach?Role of this strategy in stage I/II NSCLC? In stage III: CM816 vs PACIFIC? @myESMO #ELCC2023

[Telma Sequeira @TelmaSequeiraMD]

@DrJNaidoo @CancerCentreIre @RCSI_Irl @Beaumont_Dublin @ASCO @myESMO @MSKCancerCenter @etop_ibcsg @HopkinsThoracic @JulieBrahmer @DrLizJaffee Congrats!